Travis Nemkov
Concepts (630)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Erythrocytes | 55 | 2026 | 757 | 8.010 |
Why?
| | Blood Preservation | 31 | 2026 | 354 | 4.540 |
Why?
| | Metabolomics | 34 | 2026 | 726 | 3.430 |
Why?
| | Metabolome | 24 | 2026 | 384 | 2.680 |
Why?
| | Hemolysis | 13 | 2025 | 243 | 2.650 |
Why?
| | Glycolysis | 23 | 2025 | 339 | 2.300 |
Why?
| | Blood Donors | 11 | 2025 | 143 | 2.290 |
Why?
| | Erythrocyte Transfusion | 14 | 2026 | 230 | 1.560 |
Why?
| | Drosophila melanogaster | 11 | 2025 | 236 | 1.510 |
Why?
| | Drosophila Proteins | 10 | 2025 | 212 | 1.370 |
Why?
| | Mass Spectrometry | 11 | 2019 | 744 | 1.270 |
Why?
| | High-Throughput Screening Assays | 4 | 2021 | 174 | 1.210 |
Why?
| | Carnitine | 4 | 2024 | 90 | 1.050 |
Why?
| | Hypoxia | 11 | 2024 | 1199 | 0.990 |
Why?
| | Energy Metabolism | 11 | 2024 | 935 | 0.940 |
Why?
| | Oxidative Stress | 15 | 2025 | 1339 | 0.930 |
Why?
| | Amino Acids | 10 | 2023 | 521 | 0.910 |
Why?
| | Animals | 78 | 2026 | 38030 | 0.870 |
Why?
| | Membrane Lipids | 2 | 2021 | 83 | 0.800 |
Why?
| | Mice | 45 | 2026 | 18329 | 0.790 |
Why?
| | Hemoglobins | 6 | 2025 | 383 | 0.790 |
Why?
| | Proteomics | 8 | 2025 | 1191 | 0.750 |
Why?
| | Shock, Hemorrhagic | 7 | 2020 | 201 | 0.740 |
Why?
| | Erythroblasts | 1 | 2022 | 19 | 0.730 |
Why?
| | Blood Platelets | 5 | 2025 | 399 | 0.720 |
Why?
| | Athletic Performance | 1 | 2023 | 75 | 0.710 |
Why?
| | Glucosephosphate Dehydrogenase Deficiency | 4 | 2025 | 34 | 0.700 |
Why?
| | Lipid Metabolism | 6 | 2021 | 525 | 0.670 |
Why?
| | Purines | 4 | 2022 | 187 | 0.670 |
Why?
| | Nonprescription Drugs | 1 | 2021 | 65 | 0.640 |
Why?
| | Receptor, Adenosine A2B | 4 | 2025 | 65 | 0.630 |
Why?
| | Physical Exertion | 1 | 2021 | 207 | 0.610 |
Why?
| | Hematopoietic Stem Cells | 4 | 2026 | 420 | 0.610 |
Why?
| | Leukemia | 2 | 2019 | 245 | 0.600 |
Why?
| | Humans | 107 | 2026 | 144261 | 0.600 |
Why?
| | Glucosephosphate Dehydrogenase | 4 | 2025 | 69 | 0.600 |
Why?
| | Prescription Drugs | 1 | 2021 | 110 | 0.600 |
Why?
| | Fatty Acids | 7 | 2024 | 450 | 0.580 |
Why?
| | Hypoxia-Inducible Factor 1, alpha Subunit | 2 | 2025 | 297 | 0.570 |
Why?
| | Carbon | 2 | 2017 | 203 | 0.570 |
Why?
| | Lymph | 2 | 2016 | 31 | 0.560 |
Why?
| | Iron | 3 | 2025 | 359 | 0.560 |
Why?
| | Cell Death | 1 | 2020 | 383 | 0.550 |
Why?
| | Hypoxanthine | 1 | 2017 | 11 | 0.540 |
Why?
| | Leukemia, Myeloid, Acute | 7 | 2020 | 682 | 0.530 |
Why?
| | Anemia | 3 | 2024 | 187 | 0.510 |
Why?
| | Muscle, Skeletal | 9 | 2025 | 1792 | 0.510 |
Why?
| | Bone Marrow | 1 | 2018 | 304 | 0.500 |
Why?
| | Oxidation-Reduction | 11 | 2025 | 1084 | 0.490 |
Why?
| | Aging | 8 | 2024 | 1964 | 0.480 |
Why?
| | Altitude Sickness | 5 | 2018 | 141 | 0.480 |
Why?
| | Nitrogen | 1 | 2017 | 170 | 0.470 |
Why?
| | Transfusion Medicine | 1 | 2015 | 16 | 0.470 |
Why?
| | Exercise Tolerance | 3 | 2025 | 283 | 0.460 |
Why?
| | Biomarkers | 10 | 2024 | 4254 | 0.450 |
Why?
| | Kynurenine | 5 | 2024 | 113 | 0.450 |
Why?
| | Mice, Inbred C57BL | 18 | 2026 | 5988 | 0.440 |
Why?
| | Inflammation | 7 | 2024 | 2877 | 0.430 |
Why?
| | Male | 54 | 2025 | 72035 | 0.430 |
Why?
| | Exercise | 3 | 2023 | 2193 | 0.420 |
Why?
| | Proteome | 5 | 2025 | 514 | 0.410 |
Why?
| | Lipids | 1 | 2019 | 700 | 0.410 |
Why?
| | Mitochondria | 8 | 2025 | 983 | 0.400 |
Why?
| | Adenosine Triphosphate | 3 | 2025 | 498 | 0.400 |
Why?
| | Taste Buds | 1 | 2015 | 212 | 0.370 |
Why?
| | Female | 52 | 2026 | 77976 | 0.360 |
Why?
| | Neoplastic Stem Cells | 4 | 2021 | 412 | 0.360 |
Why?
| | Healthy Volunteers | 7 | 2021 | 214 | 0.350 |
Why?
| | Extracellular Vesicles | 2 | 2025 | 170 | 0.340 |
Why?
| | Hemorrhage | 2 | 2022 | 809 | 0.340 |
Why?
| | Chromatography, High Pressure Liquid | 7 | 2019 | 593 | 0.340 |
Why?
| | Oxygen | 5 | 2020 | 995 | 0.330 |
Why?
| | Adaptation, Physiological | 4 | 2018 | 569 | 0.310 |
Why?
| | Adult | 29 | 2025 | 40262 | 0.310 |
Why?
| | Flavones | 2 | 2019 | 11 | 0.310 |
Why?
| | Glutathione | 4 | 2025 | 375 | 0.300 |
Why?
| | Drug Resistance, Neoplasm | 3 | 2021 | 881 | 0.300 |
Why?
| | Sphingosine | 3 | 2023 | 45 | 0.300 |
Why?
| | Bridged Bicyclo Compounds, Heterocyclic | 3 | 2020 | 279 | 0.300 |
Why?
| | Altitude | 4 | 2023 | 473 | 0.290 |
Why?
| | Blood Banks | 3 | 2019 | 50 | 0.290 |
Why?
| | Rats, Sprague-Dawley | 8 | 2020 | 2525 | 0.290 |
Why?
| | Myelodysplastic Syndromes | 2 | 2023 | 147 | 0.290 |
Why?
| | Lysophospholipids | 3 | 2023 | 77 | 0.290 |
Why?
| | Adenine | 2 | 2025 | 339 | 0.280 |
Why?
| | Neoplasm Proteins | 2 | 2025 | 442 | 0.270 |
Why?
| | Alcohol Oxidoreductases | 2 | 2025 | 62 | 0.270 |
Why?
| | Polyamines | 3 | 2024 | 42 | 0.270 |
Why?
| | Tumor Necrosis Factor-alpha | 2 | 2025 | 1217 | 0.260 |
Why?
| | Acclimatization | 3 | 2018 | 172 | 0.260 |
Why?
| | Cold Temperature | 3 | 2025 | 207 | 0.260 |
Why?
| | Blood Transfusion | 4 | 2024 | 405 | 0.260 |
Why?
| | Thrombosis | 2 | 2022 | 393 | 0.260 |
Why?
| | RNA-Binding Proteins | 3 | 2023 | 462 | 0.250 |
Why?
| | fms-Like Tyrosine Kinase 3 | 2 | 2017 | 49 | 0.250 |
Why?
| | Arginine | 3 | 2024 | 262 | 0.250 |
Why?
| | Hematopoiesis | 2 | 2018 | 194 | 0.250 |
Why?
| | Larva | 6 | 2025 | 242 | 0.250 |
Why?
| | Mammals | 3 | 2023 | 291 | 0.250 |
Why?
| | Erythrocyte Aging | 2 | 2024 | 12 | 0.240 |
Why?
| | Gene Expression Regulation, Leukemic | 2 | 2016 | 56 | 0.240 |
Why?
| | Sciuridae | 2 | 2019 | 152 | 0.240 |
Why?
| | Plasma | 3 | 2017 | 224 | 0.240 |
Why?
| | Chemokine CXCL13 | 1 | 2026 | 15 | 0.240 |
Why?
| | Oxygen Consumption | 4 | 2024 | 724 | 0.240 |
Why?
| | Cysteine | 2 | 2025 | 210 | 0.240 |
Why?
| | Cell Line, Tumor | 11 | 2026 | 3539 | 0.240 |
Why?
| | Signal Transduction | 9 | 2025 | 5221 | 0.240 |
Why?
| | Focal Adhesion Kinase 1 | 1 | 2026 | 32 | 0.240 |
Why?
| | Isotope Labeling | 2 | 2017 | 82 | 0.240 |
Why?
| | Tryptophan | 4 | 2021 | 180 | 0.240 |
Why?
| | Wolbachia | 1 | 2025 | 3 | 0.240 |
Why?
| | Amino Acids, Branched-Chain | 1 | 2026 | 39 | 0.230 |
Why?
| | Anti-Inflammatory Agents | 2 | 2021 | 474 | 0.230 |
Why?
| | Mice, Knockout | 6 | 2025 | 3119 | 0.230 |
Why?
| | Macrophages, Peritoneal | 1 | 2026 | 89 | 0.230 |
Why?
| | Insulin Resistance | 3 | 2021 | 1232 | 0.230 |
Why?
| | Maternal Nutritional Physiological Phenomena | 2 | 2018 | 181 | 0.230 |
Why?
| | Drosophila | 2 | 2024 | 166 | 0.230 |
Why?
| | Collagen | 2 | 2020 | 455 | 0.230 |
Why?
| | Erythropoiesis | 2 | 2023 | 57 | 0.230 |
Why?
| | Glycerolphosphate Dehydrogenase | 1 | 2025 | 5 | 0.230 |
Why?
| | Qa-SNARE Proteins | 1 | 2025 | 19 | 0.230 |
Why?
| | Rats | 7 | 2021 | 5592 | 0.230 |
Why?
| | Wounds and Injuries | 3 | 2020 | 952 | 0.230 |
Why?
| | Pneumonia, Viral | 2 | 2020 | 382 | 0.220 |
Why?
| | Coronavirus Infections | 2 | 2020 | 377 | 0.220 |
Why?
| | Interleukin-1 | 2 | 2021 | 961 | 0.220 |
Why?
| | L-Lactate Dehydrogenase | 1 | 2025 | 115 | 0.220 |
Why?
| | Caffeine | 1 | 2025 | 74 | 0.220 |
Why?
| | Pentose Phosphate Pathway | 4 | 2018 | 55 | 0.220 |
Why?
| | Polymorphism, Genetic | 2 | 2025 | 612 | 0.220 |
Why?
| | Primaquine | 1 | 2024 | 7 | 0.220 |
Why?
| | Symbiosis | 1 | 2025 | 81 | 0.220 |
Why?
| | GTP Phosphohydrolases | 1 | 2025 | 93 | 0.220 |
Why?
| | Homeodomain Proteins | 2 | 2020 | 523 | 0.220 |
Why?
| | Phosphofructokinases | 1 | 2024 | 7 | 0.220 |
Why?
| | Fatty Acids, Omega-3 | 1 | 2026 | 142 | 0.210 |
Why?
| | Solute Carrier Family 22 Member 5 | 1 | 2024 | 7 | 0.210 |
Why?
| | Hexokinase | 1 | 2024 | 18 | 0.210 |
Why?
| | Rejuvenation | 1 | 2024 | 18 | 0.210 |
Why?
| | Physical Conditioning, Animal | 2 | 2025 | 243 | 0.210 |
Why?
| | Stress, Physiological | 2 | 2025 | 453 | 0.210 |
Why?
| | Triple Negative Breast Neoplasms | 2 | 2018 | 215 | 0.210 |
Why?
| | Cardiorespiratory Fitness | 1 | 2024 | 72 | 0.210 |
Why?
| | Large Neutral Amino Acid-Transporter 1 | 1 | 2024 | 17 | 0.210 |
Why?
| | Blood Group Antigens | 1 | 2023 | 15 | 0.210 |
Why?
| | Mitochondria, Muscle | 3 | 2021 | 121 | 0.200 |
Why?
| | Rh-Hr Blood-Group System | 1 | 2023 | 14 | 0.200 |
Why?
| | In Vitro Techniques | 3 | 2021 | 1047 | 0.200 |
Why?
| | Pyruvate Kinase | 1 | 2023 | 27 | 0.200 |
Why?
| | DNA, Mitochondrial | 1 | 2025 | 210 | 0.200 |
Why?
| | Erythrocyte Deformability | 2 | 2021 | 23 | 0.200 |
Why?
| | Uric Acid | 1 | 2025 | 166 | 0.200 |
Why?
| | Emtricitabine | 1 | 2025 | 205 | 0.200 |
Why?
| | Middle Aged | 15 | 2025 | 35762 | 0.200 |
Why?
| | Chromatography, Liquid | 3 | 2025 | 454 | 0.200 |
Why?
| | Glutamine | 3 | 2019 | 109 | 0.200 |
Why?
| | Epithelial-Mesenchymal Transition | 3 | 2021 | 219 | 0.200 |
Why?
| | Satellite Cells, Skeletal Muscle | 1 | 2023 | 30 | 0.200 |
Why?
| | Isoenzymes | 1 | 2024 | 299 | 0.200 |
Why?
| | Cerebral Hemorrhage | 1 | 2024 | 120 | 0.200 |
Why?
| | Phosphotransferases (Alcohol Group Acceptor) | 2 | 2021 | 48 | 0.200 |
Why?
| | Succinates | 1 | 2023 | 24 | 0.200 |
Why?
| | Lactates | 1 | 2023 | 83 | 0.190 |
Why?
| | Furin | 1 | 2022 | 13 | 0.190 |
Why?
| | Oxidative Phosphorylation | 3 | 2018 | 210 | 0.190 |
Why?
| | Tenofovir | 1 | 2025 | 295 | 0.190 |
Why?
| | Streptococcus pneumoniae | 1 | 2025 | 177 | 0.190 |
Why?
| | Gonadotropin-Releasing Hormone | 1 | 2024 | 212 | 0.190 |
Why?
| | Pluripotent Stem Cells | 1 | 2023 | 84 | 0.190 |
Why?
| | 2,3-Diphosphoglycerate | 5 | 2023 | 32 | 0.190 |
Why?
| | Down-Regulation | 1 | 2025 | 627 | 0.190 |
Why?
| | Mitochondrial Proteins | 1 | 2025 | 261 | 0.190 |
Why?
| | Autophagy | 1 | 2025 | 285 | 0.190 |
Why?
| | Protein Processing, Post-Translational | 3 | 2025 | 477 | 0.190 |
Why?
| | Equidae | 1 | 2022 | 7 | 0.190 |
Why?
| | src-Family Kinases | 1 | 2023 | 93 | 0.190 |
Why?
| | Histiocytosis | 1 | 2022 | 9 | 0.180 |
Why?
| | Obesity | 5 | 2021 | 3057 | 0.180 |
Why?
| | Alleles | 1 | 2025 | 878 | 0.180 |
Why?
| | Bicycling | 1 | 2023 | 120 | 0.180 |
Why?
| | AMP-Activated Protein Kinases | 3 | 2022 | 190 | 0.180 |
Why?
| | Glucose | 3 | 2017 | 1046 | 0.180 |
Why?
| | Peptide Hydrolases | 1 | 2022 | 105 | 0.180 |
Why?
| | Erdheim-Chester Disease | 1 | 2021 | 4 | 0.180 |
Why?
| | Liver | 3 | 2019 | 1884 | 0.180 |
Why?
| | Neutrophils | 2 | 2025 | 1134 | 0.170 |
Why?
| | Sulfonamides | 3 | 2020 | 580 | 0.170 |
Why?
| | Embryo, Mammalian | 1 | 2022 | 232 | 0.170 |
Why?
| | Cholesterol | 2 | 2022 | 399 | 0.170 |
Why?
| | Transgender Persons | 1 | 2024 | 190 | 0.170 |
Why?
| | Asparagine | 2 | 2018 | 35 | 0.170 |
Why?
| | Ranitidine | 1 | 2021 | 14 | 0.170 |
Why?
| | Sphingolipids | 2 | 2021 | 83 | 0.170 |
Why?
| | Erythrocyte Count | 1 | 2021 | 21 | 0.170 |
Why?
| | Auditory Pathways | 1 | 2021 | 53 | 0.170 |
Why?
| | Hydrophobic and Hydrophilic Interactions | 2 | 2019 | 191 | 0.170 |
Why?
| | Lactic Acid | 5 | 2024 | 302 | 0.170 |
Why?
| | Metformin | 1 | 2024 | 315 | 0.170 |
Why?
| | Stearoyl-CoA Desaturase | 1 | 2021 | 66 | 0.170 |
Why?
| | Protein Domains | 1 | 2022 | 313 | 0.170 |
Why?
| | Fatty Acid Desaturases | 1 | 2021 | 31 | 0.170 |
Why?
| | Proto-Oncogene Proteins p21(ras) | 1 | 2022 | 253 | 0.170 |
Why?
| | Syndecan-1 | 1 | 2020 | 42 | 0.160 |
Why?
| | Metabolic Networks and Pathways | 2 | 2019 | 187 | 0.160 |
Why?
| | Virulence Factors | 1 | 2022 | 172 | 0.160 |
Why?
| | Resistance Training | 1 | 2023 | 180 | 0.160 |
Why?
| | Benzothiazoles | 2 | 2017 | 40 | 0.160 |
Why?
| | Testosterone | 1 | 2024 | 419 | 0.160 |
Why?
| | Cell Plasticity | 1 | 2021 | 37 | 0.160 |
Why?
| | Genome-Wide Association Study | 2 | 2024 | 1406 | 0.160 |
Why?
| | Cellular Microenvironment | 1 | 2021 | 94 | 0.160 |
Why?
| | Aged | 8 | 2024 | 25850 | 0.160 |
Why?
| | Stromal Cells | 1 | 2020 | 124 | 0.160 |
Why?
| | Cellular Reprogramming | 2 | 2021 | 103 | 0.160 |
Why?
| | Leukemia, Myelogenous, Chronic, BCR-ABL Positive | 1 | 2021 | 127 | 0.160 |
Why?
| | Small Molecule Libraries | 1 | 2021 | 110 | 0.160 |
Why?
| | Osmotic Pressure | 1 | 2020 | 39 | 0.160 |
Why?
| | Tandem Mass Spectrometry | 3 | 2025 | 576 | 0.160 |
Why?
| | Cannabidiol | 1 | 2022 | 136 | 0.160 |
Why?
| | Phosphatidylserines | 1 | 2020 | 60 | 0.150 |
Why?
| | TCF Transcription Factors | 1 | 2019 | 19 | 0.150 |
Why?
| | Cannabinoids | 1 | 2022 | 182 | 0.150 |
Why?
| | Taurine | 1 | 2020 | 41 | 0.150 |
Why?
| | Macrophage Activation | 1 | 2021 | 193 | 0.150 |
Why?
| | Phenylurea Compounds | 2 | 2017 | 112 | 0.150 |
Why?
| | Topoisomerase II Inhibitors | 1 | 2019 | 26 | 0.150 |
Why?
| | Macrophages | 4 | 2022 | 1510 | 0.150 |
Why?
| | Time Factors | 10 | 2024 | 7155 | 0.150 |
Why?
| | Ovarian Neoplasms | 1 | 2026 | 586 | 0.150 |
Why?
| | Transcription Factors | 2 | 2025 | 1739 | 0.150 |
Why?
| | Parabiosis | 1 | 2019 | 11 | 0.150 |
Why?
| | Hibernation | 2 | 2019 | 80 | 0.150 |
Why?
| | Proto-Oncogene Proteins B-raf | 1 | 2021 | 225 | 0.150 |
Why?
| | STAT3 Transcription Factor | 1 | 2021 | 207 | 0.150 |
Why?
| | Shock | 1 | 2020 | 108 | 0.150 |
Why?
| | Tryptophan Oxygenase | 2 | 2018 | 33 | 0.150 |
Why?
| | Hydrogen Peroxide | 1 | 2021 | 336 | 0.150 |
Why?
| | Thyroid Neoplasms | 1 | 2023 | 343 | 0.150 |
Why?
| | Torpor | 1 | 2019 | 19 | 0.150 |
Why?
| | Circadian Clocks | 1 | 2019 | 59 | 0.140 |
Why?
| | Cell Proliferation | 6 | 2026 | 2494 | 0.140 |
Why?
| | Quantitative Trait Loci | 3 | 2025 | 374 | 0.140 |
Why?
| | CD8-Positive T-Lymphocytes | 1 | 2025 | 917 | 0.140 |
Why?
| | Cigarette Smoking | 1 | 2020 | 99 | 0.140 |
Why?
| | Homeostasis | 2 | 2022 | 640 | 0.140 |
Why?
| | Gene-Environment Interaction | 1 | 2020 | 180 | 0.140 |
Why?
| | Aspartic Acid | 1 | 2018 | 88 | 0.140 |
Why?
| | Hydrogen-Ion Concentration | 3 | 2024 | 561 | 0.140 |
Why?
| | Blood Specimen Collection | 1 | 2018 | 38 | 0.140 |
Why?
| | Anemia, Sickle Cell | 2 | 2024 | 309 | 0.140 |
Why?
| | Adenosine | 2 | 2017 | 254 | 0.140 |
Why?
| | Machine Learning | 2 | 2021 | 585 | 0.140 |
Why?
| | Arousal | 1 | 2019 | 157 | 0.140 |
Why?
| | Renal Insufficiency | 1 | 2020 | 168 | 0.140 |
Why?
| | Bile Acids and Salts | 1 | 2019 | 164 | 0.140 |
Why?
| | Stem Cell Niche | 1 | 2018 | 58 | 0.140 |
Why?
| | Hypertension, Pulmonary | 2 | 2021 | 1980 | 0.140 |
Why?
| | Deamination | 1 | 2017 | 6 | 0.140 |
Why?
| | Proteostasis | 1 | 2018 | 27 | 0.140 |
Why?
| | Macrophages, Alveolar | 1 | 2021 | 368 | 0.140 |
Why?
| | Erythrocytes, Abnormal | 1 | 2017 | 14 | 0.140 |
Why?
| | Hemoglobin A | 1 | 2017 | 21 | 0.130 |
Why?
| | Vascular Diseases | 1 | 2020 | 250 | 0.130 |
Why?
| | Hemoglobin, Sickle | 1 | 2017 | 19 | 0.130 |
Why?
| | Benzeneacetamides | 1 | 2017 | 8 | 0.130 |
Why?
| | Diglycerides | 1 | 2018 | 59 | 0.130 |
Why?
| | Cryopreservation | 1 | 2018 | 110 | 0.130 |
Why?
| | Glutaminase | 1 | 2017 | 11 | 0.130 |
Why?
| | Transcriptome | 2 | 2021 | 1044 | 0.130 |
Why?
| | Anti-HIV Agents | 1 | 2025 | 869 | 0.130 |
Why?
| | Calcium | 2 | 2022 | 1182 | 0.130 |
Why?
| | Disease Models, Animal | 7 | 2025 | 4556 | 0.130 |
Why?
| | Thiadiazoles | 1 | 2017 | 27 | 0.130 |
Why?
| | Nicotine | 1 | 2020 | 331 | 0.130 |
Why?
| | Folic Acid Deficiency | 1 | 2017 | 49 | 0.130 |
Why?
| | Immune System | 1 | 2018 | 179 | 0.130 |
Why?
| | Equilibrative Nucleoside Transporter 1 | 1 | 2017 | 20 | 0.130 |
Why?
| | Resuscitation | 2 | 2018 | 302 | 0.130 |
Why?
| | Limit of Detection | 1 | 2017 | 97 | 0.130 |
Why?
| | Basigin | 1 | 2017 | 24 | 0.130 |
Why?
| | Body Fluids | 1 | 2017 | 70 | 0.130 |
Why?
| | Tumor Microenvironment | 2 | 2018 | 732 | 0.130 |
Why?
| | Nitriles | 1 | 2018 | 205 | 0.120 |
Why?
| | Glyceraldehyde 3-Phosphate Dehydrogenase (NADP+) | 1 | 2016 | 7 | 0.120 |
Why?
| | Mutation | 6 | 2025 | 4085 | 0.120 |
Why?
| | Citric Acid | 1 | 2016 | 34 | 0.120 |
Why?
| | Polymorphism, Single Nucleotide | 1 | 2024 | 2143 | 0.120 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2018 | 169 | 0.120 |
Why?
| | Ataxia Telangiectasia Mutated Proteins | 1 | 2016 | 69 | 0.120 |
Why?
| | Young Adult | 8 | 2021 | 13990 | 0.120 |
Why?
| | Inflammasomes | 1 | 2018 | 146 | 0.120 |
Why?
| | Saline Solution, Hypertonic | 1 | 2016 | 42 | 0.120 |
Why?
| | Cell Transformation, Neoplastic | 1 | 2018 | 339 | 0.120 |
Why?
| | Gene Expression Regulation, Developmental | 4 | 2025 | 905 | 0.120 |
Why?
| | Cyclin-Dependent Kinase Inhibitor p21 | 1 | 2016 | 112 | 0.120 |
Why?
| | Interleukin-6 | 1 | 2020 | 780 | 0.120 |
Why?
| | Folic Acid | 1 | 2017 | 199 | 0.120 |
Why?
| | Neoplasms | 2 | 2022 | 2870 | 0.120 |
Why?
| | Breast Neoplasms | 2 | 2020 | 2447 | 0.120 |
Why?
| | Diethylhexyl Phthalate | 1 | 2015 | 15 | 0.120 |
Why?
| | Phosphatidylethanolamines | 1 | 2016 | 76 | 0.120 |
Why?
| | Reperfusion Injury | 1 | 2018 | 300 | 0.120 |
Why?
| | NF-E2-Related Factor 2 | 1 | 2016 | 95 | 0.120 |
Why?
| | Brain Death | 1 | 2016 | 60 | 0.120 |
Why?
| | Antioxidants | 1 | 2019 | 549 | 0.120 |
Why?
| | Membrane Transport Proteins | 1 | 2017 | 154 | 0.120 |
Why?
| | Metabolic Flux Analysis | 1 | 2015 | 7 | 0.120 |
Why?
| | Reactive Oxygen Species | 4 | 2022 | 621 | 0.120 |
Why?
| | Models, Biological | 2 | 2021 | 1820 | 0.110 |
Why?
| | Biochemistry | 1 | 2015 | 36 | 0.110 |
Why?
| | Anoikis | 1 | 2015 | 30 | 0.110 |
Why?
| | Bacteria | 1 | 2022 | 889 | 0.110 |
Why?
| | Hydroxylysine | 1 | 2015 | 4 | 0.110 |
Why?
| | Non-alcoholic Fatty Liver Disease | 1 | 2018 | 265 | 0.110 |
Why?
| | Acidosis | 1 | 2016 | 105 | 0.110 |
Why?
| | Bronchoalveolar Lavage | 1 | 2015 | 89 | 0.110 |
Why?
| | Phosphatidylcholines | 1 | 2016 | 130 | 0.110 |
Why?
| | Cognitive Dysfunction | 1 | 2021 | 451 | 0.110 |
Why?
| | Glutarates | 2 | 2025 | 11 | 0.110 |
Why?
| | Vasodilation | 1 | 2018 | 522 | 0.110 |
Why?
| | Fluid Therapy | 1 | 2016 | 147 | 0.110 |
Why?
| | Receptors, Aryl Hydrocarbon | 1 | 2015 | 60 | 0.110 |
Why?
| | Blood Volume | 1 | 2015 | 65 | 0.110 |
Why?
| | Citrates | 1 | 2014 | 41 | 0.110 |
Why?
| | Pandemics | 2 | 2020 | 1682 | 0.110 |
Why?
| | Immunity, Innate | 1 | 2021 | 846 | 0.110 |
Why?
| | Brain Injuries, Traumatic | 1 | 2021 | 441 | 0.110 |
Why?
| | Platelet Transfusion | 1 | 2015 | 80 | 0.110 |
Why?
| | Amyloid beta-Peptides | 1 | 2017 | 240 | 0.110 |
Why?
| | Renal Insufficiency, Chronic | 1 | 2021 | 653 | 0.110 |
Why?
| | Cytoskeletal Proteins | 1 | 2015 | 156 | 0.110 |
Why?
| | Extinction, Biological | 1 | 2015 | 38 | 0.110 |
Why?
| | Organ Preservation Solutions | 1 | 2014 | 47 | 0.110 |
Why?
| | Mice, Transgenic | 4 | 2025 | 2182 | 0.110 |
Why?
| | Cells, Cultured | 5 | 2021 | 4146 | 0.110 |
Why?
| | Sulfur | 3 | 2022 | 64 | 0.110 |
Why?
| | Linear Models | 1 | 2017 | 850 | 0.110 |
Why?
| | Adipose Tissue | 2 | 2017 | 651 | 0.110 |
Why?
| | Bronchoalveolar Lavage Fluid | 1 | 2017 | 636 | 0.110 |
Why?
| | Reproducibility of Results | 2 | 2026 | 3403 | 0.110 |
Why?
| | Health Status | 1 | 2019 | 833 | 0.100 |
Why?
| | Sodium Chloride | 1 | 2014 | 141 | 0.100 |
Why?
| | Endothelium, Vascular | 1 | 2020 | 963 | 0.100 |
Why?
| | Phosphates | 1 | 2014 | 179 | 0.100 |
Why?
| | Methionine | 3 | 2020 | 162 | 0.100 |
Why?
| | Proteolysis | 3 | 2020 | 173 | 0.100 |
Why?
| | Heart Ventricles | 1 | 2018 | 756 | 0.100 |
Why?
| | Peptide Fragments | 1 | 2017 | 698 | 0.100 |
Why?
| | Fetal Development | 1 | 2016 | 299 | 0.100 |
Why?
| | Dietary Supplements | 1 | 2017 | 575 | 0.100 |
Why?
| | Glucose Tolerance Test | 3 | 2021 | 360 | 0.100 |
Why?
| | Antineoplastic Agents | 3 | 2019 | 2192 | 0.100 |
Why?
| | Diabetes Mellitus, Type 2 | 3 | 2023 | 2516 | 0.090 |
Why?
| | Prognosis | 1 | 2021 | 4278 | 0.090 |
Why?
| | Muscles | 2 | 2023 | 333 | 0.090 |
Why?
| | Tumor Suppressor Protein p53 | 1 | 2016 | 529 | 0.090 |
Why?
| | Diet | 1 | 2020 | 1271 | 0.090 |
Why?
| | Nuclear Proteins | 1 | 2017 | 748 | 0.090 |
Why?
| | MicroRNAs | 1 | 2018 | 700 | 0.090 |
Why?
| | Prenatal Exposure Delayed Effects | 1 | 2018 | 674 | 0.090 |
Why?
| | Colorectal Neoplasms | 1 | 2019 | 844 | 0.090 |
Why?
| | Glyceraldehyde-3-Phosphate Dehydrogenase (Phosphorylating) | 2 | 2025 | 16 | 0.090 |
Why?
| | Nerve Tissue Proteins | 1 | 2015 | 592 | 0.090 |
Why?
| | Mice, Inbred NOD | 3 | 2017 | 610 | 0.080 |
Why?
| | Microbiota | 1 | 2018 | 781 | 0.080 |
Why?
| | Xenograft Model Antitumor Assays | 3 | 2019 | 928 | 0.080 |
Why?
| | Liver Neoplasms | 1 | 2016 | 780 | 0.080 |
Why?
| | Epithelial Cells | 1 | 2016 | 1125 | 0.080 |
Why?
| | Protein Kinase Inhibitors | 3 | 2023 | 968 | 0.080 |
Why?
| | Citric Acid Cycle | 2 | 2021 | 59 | 0.080 |
Why?
| | Cell Line | 3 | 2022 | 2879 | 0.080 |
Why?
| | HIV Infections | 1 | 2025 | 3079 | 0.080 |
Why?
| | Bisphosphoglycerate Mutase | 2 | 2021 | 7 | 0.070 |
Why?
| | Insulin | 2 | 2021 | 2501 | 0.070 |
Why?
| | Phenotype | 4 | 2020 | 3157 | 0.070 |
Why?
| | Cattle | 2 | 2022 | 999 | 0.070 |
Why?
| | Glucose Clamp Technique | 2 | 2021 | 199 | 0.070 |
Why?
| | Phosphorylation | 3 | 2018 | 1732 | 0.070 |
Why?
| | Pancreatic Neoplasms | 1 | 2017 | 918 | 0.070 |
Why?
| | Fatty Acids, Nonesterified | 2 | 2020 | 158 | 0.070 |
Why?
| | Diet, High-Fat | 2 | 2019 | 261 | 0.070 |
Why?
| | Macaca | 2 | 2018 | 65 | 0.070 |
Why?
| | Adolescent | 3 | 2024 | 22281 | 0.070 |
Why?
| | Betacoronavirus | 2 | 2020 | 285 | 0.070 |
Why?
| | Enzyme Activation | 2 | 2021 | 765 | 0.070 |
Why?
| | Brain | 2 | 2021 | 2930 | 0.060 |
Why?
| | Microscopy, Electron, Scanning | 2 | 2018 | 199 | 0.060 |
Why?
| | Bacterial Proteins | 2 | 2025 | 954 | 0.060 |
Why?
| | Apoptosis | 3 | 2021 | 2430 | 0.060 |
Why?
| | Sex Characteristics | 2 | 2023 | 789 | 0.060 |
Why?
| | Gene Expression Regulation, Neoplastic | 3 | 2018 | 1455 | 0.060 |
Why?
| | Antineoplastic Combined Chemotherapy Protocols | 1 | 2016 | 1953 | 0.060 |
Why?
| | 5'-Nucleotidase | 2 | 2017 | 49 | 0.060 |
Why?
| | GPI-Linked Proteins | 2 | 2017 | 80 | 0.060 |
Why?
| | Epigenesis, Genetic | 2 | 2021 | 684 | 0.060 |
Why?
| | Cell Adhesion | 2 | 2018 | 454 | 0.060 |
Why?
| | Molecular Targeted Therapy | 2 | 2019 | 431 | 0.060 |
Why?
| | Mice, Nude | 2 | 2018 | 682 | 0.060 |
Why?
| | Neurons | 1 | 2015 | 1640 | 0.060 |
Why?
| | Pupa | 1 | 2025 | 14 | 0.060 |
Why?
| | Biopsy | 2 | 2020 | 1075 | 0.060 |
Why?
| | Isotonic Solutions | 2 | 2016 | 39 | 0.060 |
Why?
| | Swine | 2 | 2018 | 831 | 0.060 |
Why?
| | Mitochondrial Membrane Transport Proteins | 1 | 2025 | 46 | 0.060 |
Why?
| | Isocitrate Dehydrogenase | 1 | 2025 | 70 | 0.060 |
Why?
| | Glucose Transport Proteins, Facilitative | 1 | 2025 | 16 | 0.060 |
Why?
| | Carbohydrate Metabolism | 1 | 2025 | 60 | 0.050 |
Why?
| | Mitochondrial Dynamics | 1 | 2025 | 40 | 0.050 |
Why?
| | Exosomes | 1 | 2026 | 104 | 0.050 |
Why?
| | Plateletpheresis | 1 | 2024 | 31 | 0.050 |
Why?
| | Deferoxamine | 1 | 2024 | 25 | 0.050 |
Why?
| | Cell Survival | 2 | 2019 | 1098 | 0.050 |
Why?
| | Lipid Peroxidation | 1 | 2025 | 160 | 0.050 |
Why?
| | Antimalarials | 1 | 2024 | 35 | 0.050 |
Why?
| | RNA Interference | 2 | 2017 | 476 | 0.050 |
Why?
| | Indoleacetic Acids | 1 | 2024 | 10 | 0.050 |
Why?
| | Alanine | 1 | 2025 | 171 | 0.050 |
Why?
| | Cell Division | 1 | 2026 | 766 | 0.050 |
Why?
| | Pyruvates | 1 | 2023 | 24 | 0.050 |
Why?
| | Cell Lineage | 1 | 2026 | 376 | 0.050 |
Why?
| | Pneumococcal Infections | 1 | 2025 | 103 | 0.050 |
Why?
| | Lipopolysaccharides | 2 | 2018 | 863 | 0.050 |
Why?
| | Blood Glucose | 3 | 2020 | 2312 | 0.050 |
Why?
| | Respiratory Therapy | 1 | 2023 | 25 | 0.050 |
Why?
| | Organophosphates | 1 | 2025 | 187 | 0.050 |
Why?
| | Systemic Inflammatory Response Syndrome | 1 | 2024 | 96 | 0.050 |
Why?
| | RNA, Small Interfering | 2 | 2016 | 634 | 0.050 |
Why?
| | Doxorubicin | 1 | 2026 | 397 | 0.050 |
Why?
| | Africa South of the Sahara | 1 | 2023 | 49 | 0.050 |
Why?
| | Puberty | 1 | 2024 | 140 | 0.050 |
Why?
| | Endothelial Cells | 2 | 2020 | 869 | 0.050 |
Why?
| | Pantothenic Acid | 1 | 2023 | 5 | 0.050 |
Why?
| | Myeloid Cells | 1 | 2024 | 148 | 0.050 |
Why?
| | CRISPR-Cas Systems | 1 | 2025 | 170 | 0.050 |
Why?
| | Acyl Coenzyme A | 1 | 2023 | 31 | 0.050 |
Why?
| | Prospective Studies | 3 | 2021 | 7970 | 0.050 |
Why?
| | Dasatinib | 1 | 2023 | 57 | 0.050 |
Why?
| | Iodine Radioisotopes | 1 | 2023 | 136 | 0.050 |
Why?
| | Cell Cycle | 1 | 2026 | 596 | 0.050 |
Why?
| | RNA Splicing Factors | 1 | 2023 | 64 | 0.050 |
Why?
| | Hand Strength | 1 | 2023 | 143 | 0.050 |
Why?
| | Heme | 1 | 2023 | 89 | 0.050 |
Why?
| | Pyrimidinones | 1 | 2023 | 126 | 0.050 |
Why?
| | Leukocytes, Mononuclear | 1 | 2025 | 573 | 0.050 |
Why?
| | Cellular Senescence | 1 | 2024 | 226 | 0.040 |
Why?
| | Gram-Negative Bacteria | 1 | 2022 | 81 | 0.040 |
Why?
| | Adipocytes | 1 | 2023 | 223 | 0.040 |
Why?
| | Thrombin | 1 | 2022 | 165 | 0.040 |
Why?
| | Cytokines | 2 | 2022 | 2061 | 0.040 |
Why?
| | Cell Movement | 2 | 2017 | 965 | 0.040 |
Why?
| | Pyridones | 1 | 2023 | 198 | 0.040 |
Why?
| | Horses | 1 | 2022 | 201 | 0.040 |
Why?
| | Subcellular Fractions | 1 | 2021 | 74 | 0.040 |
Why?
| | Oncogenes | 1 | 2021 | 119 | 0.040 |
Why?
| | Pyruvic Acid | 1 | 2021 | 55 | 0.040 |
Why?
| | Dogs | 1 | 2022 | 437 | 0.040 |
Why?
| | RNA, Messenger | 2 | 2022 | 2829 | 0.040 |
Why?
| | Candidiasis | 1 | 2021 | 64 | 0.040 |
Why?
| | Culture Media, Conditioned | 1 | 2021 | 111 | 0.040 |
Why?
| | Protein-Lysine 6-Oxidase | 1 | 2020 | 14 | 0.040 |
Why?
| | Blood Coagulation | 1 | 2022 | 268 | 0.040 |
Why?
| | Immunity | 1 | 2021 | 139 | 0.040 |
Why?
| | Fatty Acids, Unsaturated | 1 | 2021 | 97 | 0.040 |
Why?
| | Cochlea | 1 | 2021 | 73 | 0.040 |
Why?
| | Point Mutation | 1 | 2021 | 243 | 0.040 |
Why?
| | Cystine | 1 | 2020 | 18 | 0.040 |
Why?
| | Phosphoproteins | 1 | 2023 | 343 | 0.040 |
Why?
| | Cohort Studies | 2 | 2021 | 5935 | 0.040 |
Why?
| | Muscle Strength | 1 | 2023 | 330 | 0.040 |
Why?
| | Coculture Techniques | 1 | 2021 | 246 | 0.040 |
Why?
| | Genome | 1 | 2022 | 306 | 0.040 |
Why?
| | Fat Body | 1 | 2020 | 8 | 0.040 |
Why?
| | Creatine | 1 | 2020 | 63 | 0.040 |
Why?
| | Niacinamide | 1 | 2020 | 86 | 0.040 |
Why?
| | Longevity | 1 | 2021 | 173 | 0.040 |
Why?
| | Nuclear Receptor Subfamily 1, Group F, Member 1 | 1 | 2019 | 3 | 0.040 |
Why?
| | Poly-ADP-Ribose Binding Proteins | 1 | 2019 | 36 | 0.040 |
Why?
| | Electron Transport Chain Complex Proteins | 1 | 2019 | 20 | 0.040 |
Why?
| | Gene Deletion | 1 | 2021 | 387 | 0.040 |
Why?
| | Quality of Life | 2 | 2023 | 3166 | 0.040 |
Why?
| | DNA Topoisomerases, Type II | 1 | 2019 | 47 | 0.040 |
Why?
| | Binding, Competitive | 1 | 2019 | 193 | 0.040 |
Why?
| | Megakaryocytes | 1 | 2019 | 34 | 0.040 |
Why?
| | Phylogeny | 1 | 2023 | 1015 | 0.040 |
Why?
| | Drug Screening Assays, Antitumor | 1 | 2019 | 191 | 0.040 |
Why?
| | Dietary Carbohydrates | 1 | 2020 | 150 | 0.040 |
Why?
| | Cryoprotective Agents | 1 | 2018 | 11 | 0.040 |
Why?
| | Osmotic Fragility | 1 | 2018 | 12 | 0.040 |
Why?
| | Macaca mulatta | 1 | 2019 | 191 | 0.040 |
Why?
| | Erythrocyte Indices | 1 | 2018 | 33 | 0.040 |
Why?
| | Transplantation, Autologous | 1 | 2020 | 290 | 0.040 |
Why?
| | Succinic Acid | 1 | 2018 | 42 | 0.040 |
Why?
| | Interleukin-3 Receptor alpha Subunit | 1 | 2018 | 17 | 0.040 |
Why?
| | Platelet Activation | 1 | 2019 | 103 | 0.040 |
Why?
| | Sex Factors | 1 | 2025 | 2096 | 0.040 |
Why?
| | Microglia | 1 | 2021 | 268 | 0.040 |
Why?
| | Drug Design | 1 | 2019 | 173 | 0.040 |
Why?
| | Glycerol | 1 | 2018 | 90 | 0.040 |
Why?
| | Double-Blind Method | 1 | 2023 | 2025 | 0.040 |
Why?
| | Acute Disease | 1 | 2021 | 1028 | 0.030 |
Why?
| | Structure-Activity Relationship | 1 | 2019 | 567 | 0.030 |
Why?
| | Creatinine | 1 | 2020 | 505 | 0.030 |
Why?
| | Transplantation, Heterologous | 1 | 2018 | 193 | 0.030 |
Why?
| | Purine Nucleotides | 1 | 2018 | 12 | 0.030 |
Why?
| | Inflammation Mediators | 1 | 2021 | 508 | 0.030 |
Why?
| | Gluconeogenesis | 1 | 2018 | 83 | 0.030 |
Why?
| | Methylation | 1 | 2018 | 242 | 0.030 |
Why?
| | Sarcolemma | 1 | 2018 | 38 | 0.030 |
Why?
| | Diet, Western | 1 | 2018 | 86 | 0.030 |
Why?
| | Feeding Behavior | 1 | 2024 | 681 | 0.030 |
Why?
| | Host-Pathogen Interactions | 1 | 2021 | 371 | 0.030 |
Why?
| | Formic Acid Esters | 1 | 2017 | 3 | 0.030 |
Why?
| | Liquid-Liquid Extraction | 1 | 2017 | 14 | 0.030 |
Why?
| | Gene Expression Regulation | 2 | 2017 | 2603 | 0.030 |
Why?
| | Crush Injuries | 1 | 2017 | 12 | 0.030 |
Why?
| | Metabolism | 1 | 2017 | 44 | 0.030 |
Why?
| | Swine, Miniature | 1 | 2017 | 89 | 0.030 |
Why?
| | Biological Transport | 1 | 2018 | 412 | 0.030 |
Why?
| | Azacitidine | 1 | 2018 | 156 | 0.030 |
Why?
| | Precursor Cells, B-Lymphoid | 1 | 2017 | 41 | 0.030 |
Why?
| | Caspase 1 | 1 | 2018 | 148 | 0.030 |
Why?
| | DNA-Binding Proteins | 1 | 2025 | 1497 | 0.030 |
Why?
| | Proto-Oncogene Proteins c-bcl-2 | 1 | 2018 | 240 | 0.030 |
Why?
| | Pyrroles | 1 | 2018 | 217 | 0.030 |
Why?
| | Rotarod Performance Test | 1 | 2017 | 15 | 0.030 |
Why?
| | Blood Proteins | 1 | 2019 | 249 | 0.030 |
Why?
| | Cross-Sectional Studies | 2 | 2020 | 5813 | 0.030 |
Why?
| | Sulfones | 1 | 2018 | 127 | 0.030 |
Why?
| | Fluorenes | 1 | 2017 | 46 | 0.030 |
Why?
| | Cytosol | 1 | 2018 | 227 | 0.030 |
Why?
| | Monocarboxylic Acid Transporters | 1 | 2017 | 21 | 0.030 |
Why?
| | Plasma Membrane Calcium-Transporting ATPases | 1 | 2017 | 10 | 0.030 |
Why?
| | Random Allocation | 1 | 2018 | 363 | 0.030 |
Why?
| | Prevalence | 1 | 2024 | 2815 | 0.030 |
Why?
| | Cystathionine | 1 | 2016 | 22 | 0.030 |
Why?
| | Anaerobiosis | 1 | 2017 | 64 | 0.030 |
Why?
| | Gene Expression | 1 | 2022 | 1487 | 0.030 |
Why?
| | Periodicity | 1 | 2016 | 58 | 0.030 |
Why?
| | Weaning | 1 | 2016 | 46 | 0.030 |
Why?
| | Longitudinal Studies | 1 | 2024 | 2926 | 0.030 |
Why?
| | Cell Respiration | 1 | 2017 | 107 | 0.030 |
Why?
| | Nucleotides | 1 | 2017 | 128 | 0.030 |
Why?
| | Femoral Fractures | 1 | 2017 | 82 | 0.030 |
Why?
| | Quality Control | 1 | 2017 | 163 | 0.030 |
Why?
| | Proteins | 1 | 2022 | 1021 | 0.030 |
Why?
| | NADP | 1 | 2016 | 55 | 0.030 |
Why?
| | Hydrazines | 1 | 2016 | 37 | 0.030 |
Why?
| | Interleukin-18 | 1 | 2018 | 235 | 0.030 |
Why?
| | Protein Folding | 1 | 2018 | 279 | 0.030 |
Why?
| | Ubiquitination | 1 | 2017 | 118 | 0.030 |
Why?
| | Bronchioles | 1 | 2016 | 29 | 0.030 |
Why?
| | Myoblasts | 1 | 2017 | 84 | 0.030 |
Why?
| | Kidney | 1 | 2024 | 1495 | 0.030 |
Why?
| | Hydrogen Sulfide | 1 | 2016 | 48 | 0.030 |
Why?
| | Sesquiterpenes | 1 | 2016 | 52 | 0.030 |
Why?
| | Discriminant Analysis | 1 | 2016 | 36 | 0.030 |
Why?
| | Deoxyglucose | 1 | 2016 | 51 | 0.030 |
Why?
| | Triglycerides | 1 | 2018 | 512 | 0.030 |
Why?
| | Muscle Proteins | 1 | 2018 | 244 | 0.030 |
Why?
| | Least-Squares Analysis | 1 | 2016 | 76 | 0.030 |
Why?
| | Cyclic AMP-Dependent Protein Kinases | 1 | 2017 | 125 | 0.030 |
Why?
| | Receptors, Interleukin-1 | 1 | 2017 | 213 | 0.030 |
Why?
| | Neoplastic Cells, Circulating | 1 | 2016 | 81 | 0.030 |
Why?
| | Cell Cycle Checkpoints | 1 | 2016 | 99 | 0.030 |
Why?
| | Mice, Mutant Strains | 1 | 2016 | 299 | 0.030 |
Why?
| | Stem Cells | 1 | 2020 | 625 | 0.030 |
Why?
| | Proteasome Endopeptidase Complex | 1 | 2017 | 159 | 0.030 |
Why?
| | Hemodynamics | 1 | 2021 | 1119 | 0.030 |
Why?
| | Analysis of Variance | 1 | 2018 | 1304 | 0.030 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2017 | 269 | 0.030 |
Why?
| | Body Temperature | 1 | 2016 | 228 | 0.030 |
Why?
| | Interleukin-1beta | 1 | 2018 | 395 | 0.030 |
Why?
| | Neurodegenerative Diseases | 1 | 2018 | 150 | 0.030 |
Why?
| | Recovery of Function | 1 | 2020 | 706 | 0.030 |
Why?
| | Tumor Burden | 1 | 2017 | 319 | 0.030 |
Why?
| | Endoplasmic Reticulum | 1 | 2018 | 266 | 0.030 |
Why?
| | Bison | 1 | 2015 | 6 | 0.030 |
Why?
| | Glutamic Acid | 1 | 2017 | 251 | 0.030 |
Why?
| | Crosses, Genetic | 1 | 2015 | 124 | 0.030 |
Why?
| | Fibroblasts | 1 | 2021 | 1032 | 0.030 |
Why?
| | Models, Molecular | 1 | 2020 | 1618 | 0.030 |
Why?
| | Gas Chromatography-Mass Spectrometry | 1 | 2015 | 131 | 0.030 |
Why?
| | Muscle Fibers, Skeletal | 1 | 2016 | 214 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2018 | 1533 | 0.030 |
Why?
| | Calcium Signaling | 1 | 2017 | 251 | 0.030 |
Why?
| | Body Size | 1 | 2015 | 95 | 0.030 |
Why?
| | Sirolimus | 1 | 2016 | 281 | 0.030 |
Why?
| | Glycosylation | 1 | 2015 | 172 | 0.030 |
Why?
| | Europe | 1 | 2015 | 412 | 0.030 |
Why?
| | Mice, SCID | 1 | 2015 | 369 | 0.030 |
Why?
| | Cluster Analysis | 1 | 2016 | 519 | 0.030 |
Why?
| | Transfection | 1 | 2017 | 938 | 0.030 |
Why?
| | Flow Cytometry | 1 | 2018 | 1172 | 0.030 |
Why?
| | Indoles | 1 | 2018 | 501 | 0.030 |
Why?
| | Pregnancy | 2 | 2018 | 7180 | 0.030 |
Why?
| | Running | 1 | 2017 | 228 | 0.030 |
Why?
| | Lysine | 1 | 2016 | 302 | 0.030 |
Why?
| | Intestines | 1 | 2017 | 358 | 0.030 |
Why?
| | Hyperglycemia | 1 | 2018 | 374 | 0.030 |
Why?
| | Biomedical Research | 1 | 2020 | 709 | 0.030 |
Why?
| | Membrane Proteins | 1 | 2020 | 1165 | 0.030 |
Why?
| | Skull | 1 | 2015 | 155 | 0.030 |
Why?
| | Seasons | 1 | 2016 | 556 | 0.030 |
Why?
| | Regression Analysis | 1 | 2016 | 998 | 0.030 |
Why?
| | Neoplasm Invasiveness | 1 | 2015 | 508 | 0.030 |
Why?
| | Postpartum Period | 1 | 2016 | 361 | 0.030 |
Why?
| | Exercise Test | 1 | 2017 | 634 | 0.030 |
Why?
| | Drug Therapy, Combination | 1 | 2016 | 1044 | 0.020 |
Why?
| | Recombinant Proteins | 1 | 2017 | 1367 | 0.020 |
Why?
| | Up-Regulation | 1 | 2016 | 851 | 0.020 |
Why?
| | Severity of Illness Index | 1 | 2021 | 2917 | 0.020 |
Why?
| | Survival Analysis | 1 | 2016 | 1382 | 0.020 |
Why?
| | Transcription, Genetic | 1 | 2019 | 1495 | 0.020 |
Why?
| | Acute Lung Injury | 1 | 2016 | 302 | 0.020 |
Why?
| | Sequence Analysis, RNA | 1 | 2015 | 442 | 0.020 |
Why?
| | Neoplasm Metastasis | 1 | 2015 | 688 | 0.020 |
Why?
| | Body Mass Index | 1 | 2021 | 2420 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2020 | 3592 | 0.020 |
Why?
| | Athletes | 1 | 2016 | 417 | 0.020 |
Why?
| | Fetus | 1 | 2016 | 803 | 0.020 |
Why?
| | NF-kappa B | 1 | 2015 | 661 | 0.020 |
Why?
| | Gastrointestinal Microbiome | 1 | 2019 | 771 | 0.020 |
Why?
| | Amino Acid Sequence | 1 | 2015 | 2154 | 0.020 |
Why?
| | Molecular Sequence Data | 1 | 2015 | 2929 | 0.020 |
Why?
| | Protein Binding | 1 | 2017 | 2270 | 0.020 |
Why?
| | Treatment Outcome | 1 | 2024 | 11643 | 0.020 |
Why?
| | Aged, 80 and over | 1 | 2019 | 8243 | 0.020 |
Why?
| | United States | 1 | 2015 | 15876 | 0.010 |
Why?
|
|
Nemkov's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|